Quest Diagnostics expected to report Q2 2025 earnings of $2.56 per share, surpassing last year.

From Yahoo Finance: 2025-07-01 09:21:00

Quest Diagnostics, Inc. is set to release its Q2 2025 earnings, with analysts predicting an adjusted EPS of $2.56, up 8.9% from the previous year. For fiscal 2025, the company is expected to report an adjusted EPS of $9.70, a 8.6% increase from fiscal 2024. Shares have surged 31.2% over the past year, outperforming the S&P 500 Index.

In Q1 2025, Quest Diagnostics exceeded earnings estimates, posting an adjusted EPS of $2.21 and revenue of $2.7 billion, boosted by increased demand for diagnostic tests. Analysts rate the stock as a “Moderate Buy,” with a price target of $186.59. As of writing, DGX is trading below this target.

Read more: What to Expect From Quest Diagnostics’ Q2 2025 Earnings Report